EFM
ATRA icon

E Fund Management’s Atara Biotherapeutics ATRA Stock Holding History

E Fund Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,282
Closed -$93K – 312
2023
Q1 		$93K Buy
1,282
+228
+22% +$22.1K 0.01% 323
2022
Q4 		$86K Sell
1,054
-413
-28% -$43K 0.01% 332
2022
Q3 		$139K Buy
1,467
+442
+43% +$49.6K 0.01% 319
2022
Q2 		$200K Buy
1,025
+248
+32% +$40.5K 0.02% 301
2022
Q1 		$180K Buy
+777
New +$247K 0.01% 303

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return